Advertisement

Science News

black couple kissing

System-Wide Failure to Protect Straight Black and Latino People From HIV

light at end of tunnel

A Second Woman May Be Naturally Cured of HIV

illustration of a liver

Mixed Outcomes for HIV-Positive People With Liver Cirrhosis

black couple kissing

System-Wide Failure to Protect Straight Black and Latino People From HIV

light at end of tunnel

A Second Woman May Be Naturally Cured of HIV

illustration of a liver

Mixed Outcomes for HIV-Positive People With Liver Cirrhosis

Long-Acting HIV Therapy Hits a Snag

Studies of islatravir and MK-8507 are put on hold after participants experience declining CD4 counts.

Measuring Protection After COVID-19 Vaccination

In people who received two doses of the Moderna vaccine, levels of antibodies correlated with protection against illness.

International AIDS Society Releases New HIV Cure Strategy

The updated report summarizes progress to date, identifies gaps and outlines recommendations for HIV cure research over the next five years.

New Report Reveals Persistent HIV Inequities Among Gay and Bi Men

Black and Latino men who have sex with men are not seeing the same improvements as white men, but innovative approaches can help.

Molnupiravir capsules (Merck)

FDA Advisors Recommend Antiviral Pill for Early COVID Treatment

Molnupiravir, the first oral antiviral for COVID-19, reduces the risk of hospitalization or death if started within five days.

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption

a US dollar symbol in a life preserver

Some People With HIV Don’t Adhere to Treatment to Save Money

There’s Never Been a Better Time to Get Pregnant If One of You Has HIV

POZ March 2019 cover U=U Undetectable = Untransmitable

Communicating Undetectable Equals Untransmittable

The Science Is Clear: With HIV, Undetectable Equals Untransmittable

4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Viral Suppression Rates Are High for Adults, Lagging for Children

While a majority of people with HIV worldwide achieve an undetectable viral load, it may not be durable over time.

Racism in Medical Settings May Reduce Willingness to Take HIV Meds

HIV stigma and worries about disclosure were also associated with lower odds of taking treatment as prescribed.

Molnupiravir capsules (Merck)

Oral Antiviral Drug Cuts COVID-19 Hospitalization [UPDATED]

Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.

Most People With HIV Respond Well to COVID Vaccines

COVID-19 vaccines are highly effective, but people with a low CD4 count or detectable viral load are at risk for poor response.

What’s the Best Way to Recruit Black Men With HIV Into Studies?

Recruiting gay and bisexual Black men living with HIV into clinical trials may be as easy as walking into a clinic.

Hot topics

#Cure

#Long-Term Survivors

Ounce of Prevention sign against a blue sky

#Prevention

PrEP written on a chalkboard

#PrEP

All Adults Can Now Get COVID-19 Vaccine Boosters

Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.

These States Are Falling Further Behind in Providing HIV PrEP

So far, it appears that there has been no catching up between early- and late-adopting states.

Newer Formulation of Tenofovir Linked to Elevated Blood Lipids

Switching from TDF to TAF was associated with a less favorable blood fat profile.

Oral Antiviral Cuts COVID-19 Hospitalization by Nearly 90%

Paxlovid dramatically reduced the risk of severe illness and death, but it must be started soon after developing symptoms.

Advertisement

Features

Newsfeed

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ